Tandem Diabetes Care Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Tandem Diabetes Care de 49.9% y 10.3% por año respectivamente. Se prevé que el BPA crezca en un 51.3% al año. Se espera que la rentabilidad financiera sea de 6.2% en 3 años.
Información clave
49.9%
Tasa de crecimiento de los beneficios
51.3%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 17.1% |
| Tasa de crecimiento de los ingresos | 10.3% |
| Rentabilidad financiera futura | 6.2% |
| Cobertura de analistas | Good |
| Última actualización | 08 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Slammed 27% Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Screens Well Here But There Might Be A Catch
Nov 16
Health Check: How Prudently Does Tandem Diabetes Care (NASDAQ:TNDM) Use Debt?
Sep 28Potential Upside For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Not Without Risk
Aug 31Tandem Diabetes: Mobi's Surprise Sales Fail To Offset Flat Operating Margin
Aug 14Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 04Is It Time To Consider Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Jul 12Is Tandem Diabetes Care (NASDAQ:TNDM) Weighed On By Its Debt Load?
Jun 18Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here
May 29Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 26% Jump Shows Its Popularity With Investors
May 10A Look At The Fair Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
May 04At US$30.10, Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Worth Looking At Closely?
Mar 26Even With A 27% Surge, Cautious Investors Are Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
Mar 08Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Feb 22Estimating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jan 14Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Rockets 63% But Many Are Still Ignoring The Company
Dec 27Is It Too Late To Consider Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Nov 12Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 53% Above Its Share Price
Oct 06Does Tandem Diabetes Care (NASDAQ:TNDM) Have A Healthy Balance Sheet?
Sep 17Should You Think About Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Now?
Aug 08Calculating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jul 03Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt Sensibly?
Jun 13Cautious Investors Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
May 06Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Jan 04Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Potentially Undervalued?
Oct 15Tandem Diabetes Care: Overpriced, Underdelivering
Sep 22An Intrinsic Calculation For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Suggests It's 50% Undervalued
Sep 10Tandem Diabetes stock falls 10% on disappointing Q2 result
Aug 03Tandem Diabetes Care acquires Capillary Biomedical; terms undisclosed
Jul 21Tandem Diabetes Care: Strong Financials And Revenue, Overpenalized For Missed Earnings
Jul 08Tandem Diabetes Care (NASDAQ:TNDM) Is Looking To Continue Growing Its Returns On Capital
Jun 20Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 43% Above Its Share Price
May 30Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 1,117 | -47 | 30 | 83 | 18 |
| 12/31/2025 | 1,007 | -81 | -3 | 72 | 21 |
| 12/31/2024 | 907 | -109 | -5 | -49 | 21 |
| 9/30/2024 | 854 | -127 | -37 | 6 | N/A |
| 6/30/2024 | 796 | -136 | -64 | -20 | N/A |
| 3/31/2024 | 770 | -141 | -67 | -21 | N/A |
| 12/31/2023 | 748 | -223 | -83 | -32 | N/A |
| 9/30/2023 | 771 | -208 | -49 | -19 | N/A |
| 6/30/2023 | 790 | -224 | -41 | 5 | N/A |
| 3/31/2023 | 795 | -204 | -33 | 18 | N/A |
| 12/31/2022 | 801 | -95 | 8 | 50 | N/A |
| 9/30/2022 | 791 | -68 | 21 | 64 | N/A |
| 6/30/2022 | 766 | -13 | 50 | 74 | N/A |
| 3/31/2022 | 738 | 6 | 74 | 96 | N/A |
| 12/31/2021 | 703 | 16 | 88 | 111 | N/A |
| 9/30/2021 | 661 | 22 | 85 | 107 | N/A |
| 6/30/2021 | 605 | 7 | 62 | 87 | N/A |
| 3/31/2021 | 542 | -25 | 45 | 74 | N/A |
| 12/31/2020 | 499 | -34 | -8 | 25 | N/A |
| 9/30/2020 | 439 | -49 | -6 | 29 | N/A |
| 6/30/2020 | 410 | -42 | 5 | 37 | N/A |
| 3/31/2020 | 394 | -17 | 1 | 25 | N/A |
| 12/31/2019 | 362 | -25 | 22 | 42 | N/A |
| 9/30/2019 | 330 | -24 | 23 | 37 | N/A |
| 6/30/2019 | 282 | -55 | 0 | 10 | N/A |
| 3/31/2019 | 223 | -113 | -4 | 0 | N/A |
| 12/31/2018 | 184 | -123 | -11 | -8 | N/A |
| 9/30/2018 | 148 | -138 | -38 | -34 | N/A |
| 6/30/2018 | 129 | -119 | N/A | -50 | N/A |
| 3/31/2018 | 116 | -82 | N/A | -58 | N/A |
| 12/31/2017 | 108 | -73 | N/A | -66 | N/A |
| 9/30/2017 | 96 | -76 | N/A | -68 | N/A |
| 6/30/2017 | 82 | -90 | N/A | -67 | N/A |
| 3/31/2017 | 83 | -87 | N/A | -66 | N/A |
| 12/31/2016 | 84 | -83 | N/A | -61 | N/A |
| 9/30/2016 | 84 | -81 | N/A | -58 | N/A |
| 6/30/2016 | 88 | -70 | N/A | -54 | N/A |
| 3/31/2016 | 81 | -72 | N/A | -59 | N/A |
| 12/31/2015 | 73 | -72 | N/A | -59 | N/A |
| 9/30/2015 | 62 | -79 | N/A | -62 | N/A |
| 6/30/2015 | 59 | -79 | N/A | -61 | N/A |
| 3/31/2015 | 54 | -79 | N/A | -60 | N/A |
| 12/31/2014 | 50 | -80 | N/A | -61 | N/A |
| 9/30/2014 | 42 | -85 | N/A | -61 | N/A |
| 6/30/2014 | 36 | -78 | N/A | -58 | N/A |
| 3/31/2014 | 32 | -74 | N/A | -56 | N/A |
| 12/31/2013 | 29 | -63 | N/A | -48 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que TNDM siga sin ser rentable en los próximos 3 años.
Beneficios vs. Mercado: Se prevé que TNDM siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: Se prevé que TNDM siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (10.3% al año) de TNDM crezcan más rápidamente que los del mercado US (9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 10.3% al año) de TNDM crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de TNDM sea baja dentro de 3 años (6.2%).